Investigational drug that targets DNA damage help could treat Alzheimer's disease

Article excerpt

Accumulation of DNA damage in the brain's neurons may contribute to the development of Alzheimer's disease. New research in FEBS Open Bio demonstrates the therapeutic potential of a drug that targets this process.